ACRO is a leading voice for safe and ethical clinical trials, working with stakeholders globally to explore new paradigms for research and development and to promote a better and more efficient clinical trial process. As such, the association looks to actively engage in EFGCP by supporting its mission and activities to ensure the highest ethical and scientific standards in clinical research globally.

ACRO is a leading voice for safe and ethical clinical trials, working with stakeholders globally to explore new paradigms for research and development and to promote a better and more efficient clinical trial process. As such, the association looks to actively engage in EFGCP by supporting its mission and activities to ensure the highest ethical and scientific standards in clinical research globally.

The EPDC selects workshops to cater for a broad audience of writers; workshop content is assessed and the programme adapted to meet the needs of EMWA members. All workshops are evaluated by participants to verify their quality and usefulness. Workshops are currently offered in the following areas: Drug Development e.g. protocol & report writing, good clinical practice, ethics and regulatory guidance; Language and Writing e.g. improving English usage, editing & proof-reading, medical & pharmaceutical English for non-native speakers; Medical Science e.g. pharmacology, epidemiology and pharmacogenetics; Medical Communication e.g. publication planning & strategy, preparing medical communication documents, conference & meeting reporting; Professional Techniques e.g. data presentation techniques, presenting statistics, using data sources and medical writing software, and Soft Skills e.g. interpersonal skills and training methods. After successfully completing eight workshops participants can obtain an EPDP specialised or multidisciplinary certificate at either the foundation or advanced level.

EMWA holds conferences twice a year in various European cities; a five day Spring and a two day Autumn meeting. Spring conference themes have included Regulatory Writing and Scientific & Medical Translation. At these conferences short workshops, seminars and plenary lectures by invited speakers are offered in addition to the EPDP to keep EMWA members up to date with the current trends and regulations.

EMWA’s other aims include providing professional and social networking opportunities, and increasing awareness of medical writing throughout Europe. These aims are met by the provision of the EMWA journal 'The Write Stuff' which is published four times a year; the EMWA website which hosts information about forthcoming conferences and training, job advertisements and freelance opportunities; and by establishing links with other organisations, e.g. The Institute of Clinical Research, to increase awareness of medical writing within the broader clinical research community and to provide cross-function training opportunities.

The ultimate goal of the EORTC is to improve the standard of cancer treatment through the testing of more effective therapeutic strategies based on drugs, surgery and/or radiotherapy that are already in use and also through the development of new drugs and other innovative approaches. This is accomplished mainly by conducting large, multicentre, prospective, randomised, phase III clinical trials. In this way, the EORTC facilitates the passage of experimental discoveries into state-of-the-art treatments.
The EORTC Headquarters is based in Brussels, Belgium, from where its various activities are coordinated and run. However, the EORTC is both multinational and multidisciplinary, and the present EORTC Network comprises over 300 hospitals or cancer centers in over 30 countries, which include:
• some 2,900 collaborators from all disciplines involved in cancer treatment and research;
• some 6,000 new patients who are enrolled each year;
• some 50 trials that are permanently open to patient entry;
• some 50,000 patients who are in follow-up;
• a database of more than 180,000 patients.
Through translational and clinical research, the EORTC offers an integrated approach to drug development, drug evaluation programs and medical practices.
The EFGCP and the EORTC share common interests and have worked together developing and conducting workshops and conferences promoting good clinical practice.

The aims of the Society are:
- To promote exchange of information between European anaesthesiologists,
- To disseminate information in regard to anaesthesiology,
- To raise the standards of the speciality by fostering and encouraging education, research, scientific progress and exchange of information,
- To promote and protect the interest of its members,
- To promote improvements in safety and quality of care of patients who are under the care of anaesthesiologists inside and outside the operating room by facilitating and harmonising the activities of national and international societies of anaesthesiologists in Europe.

ESA is also establishing a Clinical Translational Research Network (CTN) in order to provide an infrastructure that allows improving the care of patients in the fields of anaesthesia, pain, intensive care and emergency medicine through transnational European collaborative investigations. The ESA CTN is managed by the ESA Research Committee in collaboration with the ESA Scientific Programme Committee and the National Anaesthesia Societies Committee, and will report to the ESA Board for its actions and activities.

ESA is organising the European Diploma in Anaesthesiology and Intensive Care Medicine (EDA) throughout Europe in 11 European languages in more than 20 Examination centres. It is a multilingual, end-of-training, two-part examination covering the relevant basic sciences and clinical subjects appropriate for a specialist anaesthesiologist. In Several European countries, the EDA Part I Exam is a mandatory Exam for the specialisation of Anaesthesiologist.

Finally, ESA organises the European Anaesthesiology Congresses throughout Europe under the banner EUROANAESTHESIA. These meetings are attended by members and non-members representing more than 80 countries from around the world. The European Anaesthesiology Congresses offer a comprehensive scientific programme of refresher course lectures, symposia and workshops, together with presentation and discussion of the latest research undertaken in Europe in particular. The European Anaesthesiology Congresses are accredited by the U.E.M.S./EACCME for C.M.E. credits. More than 6000 delegates attend the congress every year and more than 100 exhibitors participate in the industrial exhibition at the Euroanaesthesia Annual Meeting each year.

ESA choose to join the EFGCP to access to the leading European and international discussions on ethics and science in clinical research, to facilitate the transfer of knowledge and skills across disciplines and sectors, and to enhance cooperation through networking and partnerships opportunities within the clinical research community.

EUCROF has created 5 working groups among which the paediatric group is working very actively in collaboration with EMA, national authorities, and EFGCP. The paediatric working group has published several articles on surveys run in various countries and is working on establishing training sessions to improve paediatric clinical trials.